阿斯利康和吉利德在ESMO会议上公布Datroway和Trodelvy治疗三阴性乳腺癌的试验结果AstraZeneca and Gilead Present Trial Results for Datroway and Trodelvy in Triple-Negative Breast Cancer at ESMO Conference

动脉网
Oct 19

by Mark Chiang马克·蒋Share To分享到AstraZeneca and Gilead presented positive trial results for their respective treatments targeting triple-negative breast cancer during the European Society for Medical ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10